HIV Testing and Brief Alcohol Intervention for Young Drinkers in the Emergency Department

Alcohol Consumption Clinical Trial

Official title:

Addressing HIV Risk in Young Unhealthy Alcohol Drinkers in the Emergency Department With Rapid HIV Testing and Brief Intervention

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01573065
• Other study ID #: 0906005270
• Status: Completed
• Phase: N/A
• First received: April 4, 2012
• Last updated: August 9, 2012
• Start date: March 2010
• Est. completion date: August 2011

Study information

• Verified date: August 2012
• Source: Yale University
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

The purpose of this study was to determine whether a brief counseling intervention coupled with rapid HIV testing was feasible and effective at decreasing alcohol consumption and sexual risk behaviors among young, unhealthy drinkers presenting to the Emergency Department.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 85
• Est. completion date: August 2011
• Est. primary completion date: May 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 40 Years

Eligibility

Inclusion Criteria:

• 18-40 years old;

• engaged in at least one sexual risk behavior in past 90 days;

• alcohol consumption greater than NIAAA guidelines for at-risk drinking;

• unknown or negative HIV status and willing to be tested;

• able to provide contact information for follow-up;

• able to provide written informed consent.

Exclusion Criteria:

• known HIV positive status;

• medically or psychiatrically unstable.

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

• Alcohol Consumption
• Alcohol Drinking
• Sexual Risk Behaviors

Intervention

Behavioral:
• Counseling intervention with rapid HIV testing
Counseling intervention (modeled after Brief Negotiation Interview and Project RESPECT-2) coupled with rapid HIV testing. Telephone booster at 2 weeks.

Locations

Country	Name	City	State
United States	Yale New Haven Hospital Emergency Deparmtment	New Haven	Connecticut

Sponsors (1)

Lead Sponsor	Collaborator
Yale University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Feasibility	number of patients enrolled and retained at 2 months.	baseline and 2 month follow-up	No
Secondary	Alcohol consumption	As assessed by the Time Line Follow Back, change in alcohol consumption.	baseline vs. 2 month follow-up	No
Secondary	Sexual risk behaviors	As assessed by an adapted HIV Risk Behaviors Scale, change in sexual risk behaviors.	baseline vs. 2 month follow-up	No